U.S. markets closed

ZIOPHARM Oncology, Inc. (ZIOP)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
2.3000+0.0300 (+1.32%)
At close: 4:00PM EDT
2.2700 -0.03 (-1.30%)
After hours: 05:54PM EDT
Get access to 40+ years of historical data with Yahoo Finance Plus Essential.Learn more
Currency in USD

Valuation Measures

Yahoo Finance Plus required to access annual data
Yahoo Finance Plus required to access monthly data
Subscribe to Yahoo Finance Plus Essential to download historical data
As of Date: 8/2/2021
Market Cap (intraday) 5
Enterprise Value 3
Trailing P/E
Forward P/E 1
PEG Ratio (5 yr expected) 1
Price/Sales (ttm)
Price/Book (mrq)
Enterprise Value/Revenue 3
Enterprise Value/EBITDA 7

Trading Information

Stock Price History

Beta (5Y Monthly) 2.01
52-Week Change 3-28.62%
S&P500 52-Week Change 333.41%
52 Week High 35.9500
52 Week Low 32.0600
50-Day Moving Average 32.5285
200-Day Moving Average 33.4708

Share Statistics

Avg Vol (3 month) 31.69M
Avg Vol (10 day) 31.24M
Shares Outstanding 5215.52M
Implied Shares Outstanding 6N/A
Float 178.14M
% Held by Insiders 19.49%
% Held by Institutions 159.72%
Shares Short (Jul 14, 2021) 435.67M
Short Ratio (Jul 14, 2021) 420.43
Short % of Float (Jul 14, 2021) 417.15%
Short % of Shares Outstanding (Jul 14, 2021) 416.55%
Shares Short (prior month Jun 14, 2021) 437.3M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 21:40
Last Split Date 3Aug 23, 2005

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 30, 2020
Most Recent Quarter (mrq)Mar 30, 2021


Profit Margin 0.00%
Operating Margin (ttm)0.00%

Management Effectiveness

Return on Assets (ttm)-31.62%
Return on Equity (ttm)-58.21%

Income Statement

Revenue (ttm)N/A
Revenue Per Share (ttm)N/A
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)-52.7M
EBITDA -81.14M
Net Income Avi to Common (ttm)-83.24M
Diluted EPS (ttm)-0.3900
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)100.06M
Total Cash Per Share (mrq)0.47
Total Debt (mrq)4.63M
Total Debt/Equity (mrq)4.38
Current Ratio (mrq)5.94
Book Value Per Share (mrq)0.49

Cash Flow Statement

Operating Cash Flow (ttm)-62.42M
Levered Free Cash Flow (ttm)-42.62M